UBA1 and proximal spinal muscular atrophy: To validate UBA1 as a therapeutic target in human SMA, we measured UBA1 protein levels in induced pluripotent stem cell–derived (iPSC-derived) motor neurons generated from type I SMA patients and controls (20).